Long-term effect of sulfionylura in permanent neonatal diabetes due to mutations in KCNJ11 encoding kir6.2

被引：0
|
作者：
Njolstad, PR
Abuelo, D
Baevre, H
Hansen, T
Hathout, E
Kirsti, A
Hogasen, M
Molven, A
Pedersen, O
Phutkul, CP
Pontynen, S
Pruhova, S
Raeder, H
Sagen, JV
Shehadeh, N
Silva, JML
Sovik, O
机构：
来源：
DIABETES | 2005年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A293 / A293
页数：1
相关论文
共 50 条
  • [41] Precision medicine in KCNJ11 permanent neonatal diabetes
    Greeley, Siri Atma W.
    Letourneau, Lisa R.
    Philipson, Louis H.
    LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (08): : 594 - 595
  • [42] The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy
    Koster, Joseph C.
    Cadario, Francesco
    Peruzzi, Cinzia
    Colombo, Carlo
    Nichols, Colin G.
    Barbetti, Fabrizio
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (03): : 1054 - 1061
  • [43] Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype
    Flanagan, SE
    Edghill, EL
    Gloyn, AL
    Ellard, S
    Hattersley, AT
    DIABETOLOGIA, 2006, 49 (06) : 1190 - 1197
  • [44] Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype
    S. E. Flanagan
    E. L. Edghill
    A. L. Gloyn
    S. Ellard
    A. T. Hattersley
    Diabetologia, 2006, 49 : 1190 - 1197
  • [45] Successful therapy with sulfonylurea in a 6 year old boy with permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2 of the KCNJ11 gene - patient characteristics and response to one year treatment
    Wagner, Verena
    Kremke, Britta
    Pearson, Ewan
    Hattersley, Andrew
    Hiort, Olaf
    HORMONE RESEARCH, 2006, 65 : 70 - 70
  • [46] Kir6.2 mutations are a common cause of permanent neonatal diabetes in a large cohort of French patients
    Vaxillaire, M
    Populaire, C
    Busiah, K
    Cavé, H
    Gloyn, AL
    Hattersley, AT
    Czernichow, P
    Froguel, P
    Polak, M
    DIABETES, 2004, 53 (10) : 2719 - 2722
  • [47] Mutations at the same residue (R50) of Kir6.2 (KCNJ11) that cause neonatal diabetes produce different functional effects (vol 55, pg 1705, 2006)
    Shimomura, K.
    Girard, C. A. J.
    Proks, P.
    Nazim, J.
    Lippiat, J. D.
    Cerutti, F.
    Lorini, R.
    Ellard, S.
    Hattersley, A. T.
    Barbetti, F.
    Ashcroft, F. M.
    DIABETES, 2007, 56 (03) : 897 - 897
  • [48] Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes
    Gloyn, AL
    Pearson, ER
    Antcliff, JF
    Proks, P
    Bruining, GJ
    Slingerland, AS
    Howard, N
    Srinivasan, S
    Silva, JMCL
    Molnes, J
    Edghill, EL
    Frayling, TM
    Temple, IK
    Mackay, D
    Shield, JPH
    Sumnik, Z
    van Rhijn, A
    Wales, JKH
    Clark, P
    Gorman, S
    Aisenberg, J
    Ellard, S
    Njolstad, PR
    Ashcroft, FM
    Hattersley, AT
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (18): : 1838 - 1849
  • [49] A Pathway to Insulin Independence: A Single Center's Experience with Permanent Neonatal Diabetes Due to Mutations in KCNJ11
    Hathout, Eba
    Chan, Nathaniel
    Ellard, Sian
    Young, Elizabeth
    Mace, John
    Njolstad, Pal
    Hattersley, Andrew
    DIABETES, 2010, 59 : A693 - A693
  • [50] Transient Neonatal Diabetes due to Kcnj11 Mutation
    Kochar, I. P. S.
    Kulkarni, K. P.
    INDIAN PEDIATRICS, 2010, 47 (04) : 359 - 360
12345